{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Revascularization vs. Non-Operative Management in Intermittent Claudication"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Eligible IC patients were randomised to either revascularization (bypass or PVI) or non-operative management (medication and exercise therapy)."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible IC patients were randomised to either revascularization (bypass or PVI) or non-operative management (medication and exercise therapy)."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Eligible IC patients were randomised to either revascularization (bypass or PVI) or non-operative management (medication and exercise therapy)."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was patient-reported physical function (PROMIS-PF) and satisfaction in social roles (PROMIS-SA) over a follow-up of up to 7 years."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable due to the nature of interventions."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 225 patients were randomised: 89 to revascularization and 136 to non-operative management."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was conducted using a linear mixed-effect model adjusted for covariates."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "No significant differences were found in PROMIS-PF between groups over time (P=0.07). PROMIS-SA improved significantly in all patients (P=0.019), with greater improvement in the non-operative group (P=0.045)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}